Pluri Inc. — Director's Dealing 2016

Feb 17, 2016

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

OMB APPROVAL

OMB Number: 3235-0287

Estimated average

burden hours

per response

0.5

Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b).

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person* SHORRER DORON 0001268788		2. Issuer Name and Ticker or Trading Symbol PLURISTEM THERAPEUTICS INC [PSTI]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) ☑ Director 10% Owner Officer (give title below) Other (specify below)
(Last) (First) (Middle) 33 KHORE HADOROT ST	3. Date of Earliest Transaction (Month/Day/Year) 02/15/2016
(Street) JERUSALEM L3 93393	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) ☑ Form filed by One Reporting Person Form filed by More than One Reporting Person
Table I – Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
---	---	---	---
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)
			Code
Common Stock	02/15/2016		P
Table II – Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
---	---	---	---
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)

Explanation of Responses:

1. The purchase was effected on the Tel Aviv Stock Exchange in New Israeli Shekels (NIS) for a per share purchase price of NIS 3.14, which per share purchase price has been reported on this Form 4 in U.S. dollars based on an exchange rate of NIS 3.889 per U.S. dollar.

Remarks:

---

/s/ Doron Shorrer ** Signature of Reporting Person 02/17/2016 Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4(b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.